Status: current, Defined. Date: 31-Aug 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2046441000168111 | benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2046451000168113 | benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | Is a | benzydamine + cetylpyridinium + pholcodine | true | Inferred relationship | Some | ||
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | Is a | pholcodine 5.5 mg + cetylpyridinium chloride 1.33 mg lozenge | true | Inferred relationship | Some | ||
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | has manufactured dose form | lozenge | true | Inferred relationship | Some | ||
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | has unit of use | lozenge | true | Inferred relationship | Some | 2112363649 | |
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | has intended active ingredient | benzydamine | true | Inferred relationship | Some | 1045604332 | |
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | has Australian BoSS | benzydamine hydrochloride | true | Inferred relationship | Some | 1045604332 | |
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | has Australian BoSS | pholcodine | true | Inferred relationship | Some | 289440676 | |
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | has intended active ingredient | pholcodine | true | Inferred relationship | Some | 289440676 | |
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | has intended active ingredient | cetylpyridinium | true | Inferred relationship | Some | 2112363648 | |
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | has Australian BoSS | cetylpyridinium chloride | true | Inferred relationship | Some | 2112363648 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Difflam Cough Lozenge Blackcurrant Sugar Free lozenge | Is a | True | benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | Inferred relationship | Some | |
| benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge, 24 lozenges (medicinal product pack) | has MPUU | True | benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride 1.33 mg + pholcodine 5.5 mg lozenge | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR